Expression and Clinical Significance of PIM1 in Newly Diagnosed Patients with Acute Myeloid Leukemia
PIM1 is overexpressed in AML patients and is associated with adverse clinicopathological characteristics and poor prognosis. PIM1 may serve as a prognostic biomarker and a potential therapeutic target in AML.
Authors
- Guizhen Su
- Wanwan Wang (ORCID: https://orcid.org/0000-0002-0981-1382)
- Qiang Li (ORCID: https://orcid.org/0000-0003-1119-8692)
- Mengmeng Zhang (ORCID: https://orcid.org/0000-0003-3207-498X)
- Zhongyu Li (ORCID: https://orcid.org/0000-0002-9566-5771)
- Guiling Liu
- Yuanyuan Tan (ORCID: https://orcid.org/0000-0002-1081-664X)
- Jiajia Li (ORCID: https://orcid.org/0000-0002-1011-4568)
- Wei Yao (ORCID: https://orcid.org/0009-0003-6652-3488)
Publication Details
- Journal
- Clinical Laboratory
- Published
- 2025-01-01
- DOI
- https://doi.org/10.7754/clin.lab.2024.241213
- Citations
- 1
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 1.47